跳至主要内容
临床试验/IRCT20121028011288N16
IRCT20121028011288N16已完成3 期

The effect of taurine supplementation on serum levels of adiponectin, irisin, fibroblast growth factor-21, sirtuin-1, metabolic parameters, oxidative, inflammatory indicators and nutritional status in patients with type 2 diabetes

Tabriz University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Patients with Type 2 Diabetes
  • Patients who use glucose lowering oral medications are well controlled by their blood glucose levels.
  • Body mass index 35-25 kg /m 2 will be included in the study.
  • age range from 30-60 years

排除标准

  • Use of multi-vitamin and mineral supplements over the past 3 months.
  • Taking corticosteroids and non-steroidal anti-inflammatory drugs.
  • Taking insulin
  • Patients with polycystic ovary syndrome
  • Patients with chronic diseases such as cardiovascular, renal and hepatic disorders, and hypothyroidism and hyperthyroidism
  • Having certain physiological conditions such as pregnancy and lactation.

研究者

相似试验

Taurine in type 2 diabetes | 临床试验